Corcept Therapeutics
CORT
#2478
Rank
HK$45.68 B
Marketcap
HK$436.05
Share price
-0.12%
Change (1 day)
115.72%
Change (1 year)

P/S ratio for Corcept Therapeutics (CORT)

P/S ratio as of November 2024 (TTM): 9.39

According to Corcept Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 9.24. At the end of 2024 the company had a P/S ratio of 7.30.

P/S ratio history for Corcept Therapeutics from 2007 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20247.305.22%
20236.9427.57%
20225.44-12.9%
20216.25-27.27%
20208.5989.9%
20194.52-26.07%
20186.12-52.75%
201712.930.61%
20169.91-8.71%
201510.9-5.22%
201411.5-62.98%
201330.9-28.3%
201243.2
2011N/A
2010N/A-100%
2009> 10006549.54%
200887.1-60.46%
2007220

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.27-54.56%๐Ÿ‡บ๐Ÿ‡ธ USA
2.49-73.50%๐Ÿ‡บ๐Ÿ‡ธ USA
4.15-55.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
17.4 85.46%๐Ÿ‡บ๐Ÿ‡ธ USA
2.55-72.86%๐Ÿ‡บ๐Ÿ‡ธ USA
4.01-57.36%๐Ÿ‡บ๐Ÿ‡ธ USA
1.75-81.34%๐Ÿ‡บ๐Ÿ‡ธ USA
7.65-18.57%๐Ÿ‡บ๐Ÿ‡ธ USA
4.38-53.41%๐Ÿ‡บ๐Ÿ‡ธ USA